Effect of SKF 525A on the release of nitric oxide and prostacyclin from endothelial cells
- 1 May 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 150 (1-2) , 149-154
- https://doi.org/10.1016/0014-2999(88)90761-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Comparative pharmacology of EDRF and nitric oxide on vascular stripsEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Stimulation of vascular prostacyclin by SKF525-A (proadifen) and related compoundsBiochemical Pharmacology, 1987
- Bioassay of prostacyclin and endothelium‐derived relaxing factor (EDRF) from porcine aortic endothelial cellsBritish Journal of Pharmacology, 1986
- Desensitization of membrane-bound Torpedo acetylcholine receptor by amine noncompetitive antagonists and aliphatic alcohols: studies of [3H]acetylcholine binding and sodium-22 ion fluxesBiochemistry, 1984
- ANTAGONISM OF CALMODULIN BY LOCAL-ANESTHETICS - INHIBITION OF CALMODULIN-STIMULATED CALCIUM-TRANSPORT OF ERYTHROCYTE INSIDE-OUT MEMBRANE-VESICLES1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- A radioimmunoassay for 6-keto- prostaglandin F1αProstaglandins, 1978